1
|
Zeleňáková A, Zeleňák V, Beňová E, Kočíková B, Király N, Hrubovčák P, Szűcsová J, Nagy Ľ, Klementová M, Mačák J, Závišová V, Bednarčík J, Kupčík J, Jacková A, Volavka D, Košuth J, Vilček Š. The surface modification of the silica-coated magnetic nanoparticles and their application in molecular diagnostics of virus infection. Sci Rep 2024; 14:14427. [PMID: 38910140 PMCID: PMC11194262 DOI: 10.1038/s41598-024-64839-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2023] [Accepted: 06/13/2024] [Indexed: 06/25/2024] Open
Abstract
The study presents a series of examples of magnetic nanoparticle systems designed for the diagnosis of viral diseases. In this interdisciplinary work, we describe one of the most comprehensive synthetic approaches for the preparation and functionalization of smart nanoparticle systems for rapid and effective RT-PCR diagnostics and isolation of viral RNA. Twelve different organic ligands and inorganic porous silica were used for surface functionalization of the Fe3O4 magnetic core to increase the number of active centres for efficient RNA binding from human swab samples. Different nanoparticle systems with common beads were characterized by HRTEM, SEM, FT-IR, XRD, XPS and magnetic measurements. We demonstrate the application of the fundamental models modified to fit the experimental zero-field cooling magnetization data. We discuss the influence of the nanoparticle shell parameters (morphology, thickness, ligands) on the overall magnetic performance of the systems. The prepared nanoparticles were tested for the isolation of viral RNA from tissue samples infected with hepatitis E virus-HEV and from biofluid samples of SARS-CoV-2 positive patients. The efficiency of RNA isolation was quantified by RT-qPCR method.
Collapse
Affiliation(s)
- A Zeleňáková
- Institute of Physics, Faculty of Science, P.J. Šafárik University, Park Angelinum 9, 04001, Košice, Slovakia.
| | - V Zeleňák
- Institute of Chemistry, Faculty of Science, P.J. Šafárik University, Moyzesova 11, 04001, Košice, Slovakia
| | - E Beňová
- Institute of Chemistry, Faculty of Science, P.J. Šafárik University, Moyzesova 11, 04001, Košice, Slovakia
| | - B Kočíková
- Department of Epizootiology, Parasitology and Public Health Protection, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 04181, Košice, Slovakia
| | - N Király
- Institute of Chemistry, Faculty of Science, P.J. Šafárik University, Moyzesova 11, 04001, Košice, Slovakia
| | - P Hrubovčák
- Institute of Physics, Faculty of Science, P.J. Šafárik University, Park Angelinum 9, 04001, Košice, Slovakia
| | - J Szűcsová
- Institute of Physics, Faculty of Science, P.J. Šafárik University, Park Angelinum 9, 04001, Košice, Slovakia
| | - Ľ Nagy
- Institute of Physics, Faculty of Science, P.J. Šafárik University, Park Angelinum 9, 04001, Košice, Slovakia
| | - M Klementová
- Institute of Physics of the CAS, v.v.i., Na Slovance 1999/2, 182 21, Praha 8, Czech Republic
| | - J Mačák
- Synlab Slovakia s. r. o Department of Clinical Microbiology, Opatovská Cesta 10, 04001, Košice, Slovakia
| | - V Závišová
- Institute of Experimental Physics, Slovak Academy of Sciences, Watsonova 47, 04001, Košice, Slovakia
| | - J Bednarčík
- Institute of Physics, Faculty of Science, P.J. Šafárik University, Park Angelinum 9, 04001, Košice, Slovakia
| | - J Kupčík
- Institute of Physics of the CAS, v.v.i., Na Slovance 1999/2, 182 21, Praha 8, Czech Republic
| | - A Jacková
- Department of Epizootiology, Parasitology and Public Health Protection, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 04181, Košice, Slovakia
| | - D Volavka
- Institute of Physics, Faculty of Science, P.J. Šafárik University, Park Angelinum 9, 04001, Košice, Slovakia
| | - J Košuth
- Institute of Biology and Ecology, Faculty of Science, P.J. Šafárik University, Šrobárova 2, 04154, Košice, Slovakia
| | - Š Vilček
- Department of Epizootiology, Parasitology and Public Health Protection, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 04181, Košice, Slovakia
| |
Collapse
|
2
|
Sidhu AK, Patil SN, Gaikwad VB. Direct binding and characterization of laccase onto iron oxide nanoparticles. NANOTECHNOLOGY 2024; 35:235101. [PMID: 38364270 DOI: 10.1088/1361-6528/ad2a02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/26/2023] [Accepted: 02/13/2024] [Indexed: 02/18/2024]
Abstract
Iron oxide nanoparticles (IONPs) exhibit unique magnetic properties and possess a high surface-to-volume ratio, making them ideal candidates for the conjugation of substances, including enzymes. Laccase (EC 1.10.3.2), an oxidative enzyme with diverse applications, presents an opportunity for enhancing stability and reusability through innovative immobilization techniques, thus reducing overall process costs. In this study, we employed a direct binding procedure via carbodiimide activation to conjugate laccase onto IONPs synthesized using thermal chemical coprecipitation. Stabilization of the nanoparticles was achieved using thioglycerol and polyvinyl alcohol (PVA) as capping agents. Characterization of the synthesized nanoparticles was conducted using UV-spectroscopy, Fourier transform infrared spectroscopy (FTIR), x-ray diffraction, scanning electron microscopy, and energy dispersive x-ray spectroscopy. FTIR spectroscopy analysis confirmed successful laccase binding to magnetic nanoparticles, with binding efficiencies of 90.65% and 73.02% observed for thioglycerol and PVA capped IONPs, respectively. Furthermore, the conjugated enzyme exhibited remarkable stability, retaining nearly 50% of its initial activity after 20 reuse cycles. This research demonstrates that immobilizing laccase onto IONPs enhances its activity, stability, and reusability, with the potential for significant cost savings and expanded applications in various fields.
Collapse
Affiliation(s)
- Amanpreet K Sidhu
- Assistant Professor, Department of Biotechnology, Khalsa College, Amritsar, Punjab, India
| | - Sucheta N Patil
- Professor, Department of Microbiology, K.T.H.M College, Nashik, Maharashtra, India
| | - Vishwas B Gaikwad
- Regional Director, Yashwantrao Chavan Maharashtra Open University, Nashik, Maharashtra, India
| |
Collapse
|
3
|
Capriotti N, Amorós Morales LC, de Sousa E, Juncal L, Pidre ML, Traverso L, López MF, Ferelli ML, Lavorato G, Lillo C, Vazquez Robaina O, Mele N, Vericat C, Schilardi P, Cabrera AF, Stewart S, Fonticelli MH, Mendoza Zéliz P, Ons S, Romanowski V, Rodríguez Torres C. Silica-coated magnetic particles for efficient RNA extraction for SARS-CoV-2 detection. Heliyon 2024; 10:e25377. [PMID: 38322940 PMCID: PMC10844049 DOI: 10.1016/j.heliyon.2024.e25377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2023] [Revised: 01/11/2024] [Accepted: 01/25/2024] [Indexed: 02/08/2024] Open
Abstract
Molecular diagnostic methods to detect and quantify viral RNA in clinical samples rely on the purification of the genetic material prior to reverse transcription polymerase chain reaction (qRT-PCR). Due to the large number of samples processed in clinical laboratories, automation has become a necessity in order to increase method processivity and maximize throughput per unit of time. An attractive option for isolating viral RNA is based on the magnetic solid phase separation procedure (MSPS) using magnetic microparticles. This method offers the advantage over other alternative methods of making it possible to automate the process. In this study, we report the results of the MSPS method based on magnetic microparticles obtained by a simple synthesis process, to purify RNA from oro- and nasopharyngeal swab samples of patients suspected of COVID-19 provided by three diagnostic laboratories located in the Buenos Aires Province, Argentina. Magnetite nanoparticles of Fe3O4 (MNPs) were synthesized by the coprecipitation method and then coated with silica (SiO2) produced by hydrolysis of tetraethyl orthosilicate (TEOS). After preliminary tests on samples from the A549 human lung cell line and swabs, an extraction protocol was developed. The quantity and purity of the RNA obtained were determined by gel electrophoresis, spectrophotometry, and qRT-PCR. Tests on samples from naso- and oropharyngeal swabs were performed in order to validate the method for RNA purification in high-throughput SARS-CoV-2 diagnosis by qRT-PCR. The method was compared to the spin columns method and the automated method using commercial magnetic particles. The results show that the method developed is efficient for RNA extraction from nasal and oropharyngeal swab samples, and also comparable to other extraction methods in terms of sensitivity for SARS-CoV-2 detection. Of note, this procedure and reagents developed locally were intended to overcome the shortage of imported diagnostic supplies as the sudden spread of COVID-19 required unexpected quantities of nucleic acid isolation and diagnostic kits worldwide.
Collapse
Affiliation(s)
- Natalia Capriotti
- Laboratorio de Neurobiología de Insectos (LNI), Centro Regional de Estudios Genómicos, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CENEXA, CONICET, La Plata, Buenos Aires, Argentina
| | - Leslie C. Amorós Morales
- Instituto de Biotecnología y Biología Molecular (IBBM), Facultad de Ciencias Exactas, Universidad Nacional de La Plata-CONICET, La Plata, Argentina
| | - Elisa de Sousa
- IFLP-CCT-La Plata-CONICET and Departamento de Física, Facultad de Ciencias Exactas, C. C. 67, Universidad Nacional de La Plata, 1900, La Plata, Argentina
| | - Luciana Juncal
- IFLP-CCT-La Plata-CONICET and Departamento de Física, Facultad de Ciencias Exactas, C. C. 67, Universidad Nacional de La Plata, 1900, La Plata, Argentina
| | - Matias Luis Pidre
- Instituto de Biotecnología y Biología Molecular (IBBM), Facultad de Ciencias Exactas, Universidad Nacional de La Plata-CONICET, La Plata, Argentina
| | - Lucila Traverso
- Laboratorio de Neurobiología de Insectos (LNI), Centro Regional de Estudios Genómicos, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CENEXA, CONICET, La Plata, Buenos Aires, Argentina
| | - Maria Florencia López
- Instituto de Biotecnología y Biología Molecular (IBBM), Facultad de Ciencias Exactas, Universidad Nacional de La Plata-CONICET, La Plata, Argentina
| | - Maria Leticia Ferelli
- Instituto de Biotecnología y Biología Molecular (IBBM), Facultad de Ciencias Exactas, Universidad Nacional de La Plata-CONICET, La Plata, Argentina
| | - Gabriel Lavorato
- Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA), Facultad de Ciencias Exactas, Universidad Nacional de La Plata - CONICET, 1900, La Plata, Buenos Aires, Argentina
| | - Cristian Lillo
- Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA), Facultad de Ciencias Exactas, Universidad Nacional de La Plata - CONICET, 1900, La Plata, Buenos Aires, Argentina
| | - Odin Vazquez Robaina
- IFLP-CCT-La Plata-CONICET and Departamento de Física, Facultad de Ciencias Exactas, C. C. 67, Universidad Nacional de La Plata, 1900, La Plata, Argentina
| | - Nicolas Mele
- IFLP-CCT-La Plata-CONICET and Departamento de Física, Facultad de Ciencias Exactas, C. C. 67, Universidad Nacional de La Plata, 1900, La Plata, Argentina
| | - Carolina Vericat
- Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA), Facultad de Ciencias Exactas, Universidad Nacional de La Plata - CONICET, 1900, La Plata, Buenos Aires, Argentina
| | - Patricia Schilardi
- Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA), Facultad de Ciencias Exactas, Universidad Nacional de La Plata - CONICET, 1900, La Plata, Buenos Aires, Argentina
| | - Alejandra Fabiana Cabrera
- IFLP-CCT-La Plata-CONICET and Departamento de Física, Facultad de Ciencias Exactas, C. C. 67, Universidad Nacional de La Plata, 1900, La Plata, Argentina
| | - Silvana Stewart
- IFLP-CCT-La Plata-CONICET and Departamento de Física, Facultad de Ciencias Exactas, C. C. 67, Universidad Nacional de La Plata, 1900, La Plata, Argentina
| | - Mariano H. Fonticelli
- Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA), Facultad de Ciencias Exactas, Universidad Nacional de La Plata - CONICET, 1900, La Plata, Buenos Aires, Argentina
| | - Pedro Mendoza Zéliz
- IFLP-CCT-La Plata-CONICET and Departamento de Física, Facultad de Ciencias Exactas, C. C. 67, Universidad Nacional de La Plata, 1900, La Plata, Argentina
| | - Sheila Ons
- Laboratorio de Neurobiología de Insectos (LNI), Centro Regional de Estudios Genómicos, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CENEXA, CONICET, La Plata, Buenos Aires, Argentina
| | - Victor Romanowski
- Instituto de Biotecnología y Biología Molecular (IBBM), Facultad de Ciencias Exactas, Universidad Nacional de La Plata-CONICET, La Plata, Argentina
| | - Claudia Rodríguez Torres
- IFLP-CCT-La Plata-CONICET and Departamento de Física, Facultad de Ciencias Exactas, C. C. 67, Universidad Nacional de La Plata, 1900, La Plata, Argentina
| |
Collapse
|
4
|
Yang Y, Liu Y, Song L, Cui X, Zhou J, Jin G, Boccaccini AR, Virtanen S. Iron oxide nanoparticle-based nanocomposites in biomedical application. Trends Biotechnol 2023; 41:1471-1487. [PMID: 37407395 DOI: 10.1016/j.tibtech.2023.06.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2023] [Revised: 05/22/2023] [Accepted: 06/07/2023] [Indexed: 07/07/2023]
Abstract
Iron-oxide-based biomagnetic nanocomposites, recognized for their significant properties, have been utilized in MRI and cancer treatment for several decades. The expansion of clinical applications is limited by the occurrence of adverse effects. These limitations are largely attributed to suboptimal material design, resulting in agglomeration, reduced magnetic relaxivity, and inadequate functionality. To address these challenges, various synthesis methods and modification strategies have been used to tailor the size, shape, and properties of iron oxide nanoparticle (FeONP)-based nanocomposites. The resulting modified nanocomposites exhibit significant potential for application in diagnostic, therapeutic, and theranostic contexts, including MRI, drug delivery, and anticancer and antimicrobial activity. Yet, their biosafety profile must be rigorously evaluated. Such efforts will facilitate the broader clinical translation of FeONP-based nanocomposites in biomedical applications.
Collapse
Affiliation(s)
- Yuyun Yang
- Institute of Corrosion Science and Surface Technology, Department of Material Science and Chemical Engineering, Harbin Engineering University, Harbin, 15001, China.
| | - Yuejun Liu
- Institute of Corrosion Science and Surface Technology, Department of Material Science and Chemical Engineering, Harbin Engineering University, Harbin, 15001, China
| | - Laiming Song
- Institute of Corrosion Science and Surface Technology, Department of Material Science and Chemical Engineering, Harbin Engineering University, Harbin, 15001, China
| | - Xiufang Cui
- Institute of Corrosion Science and Surface Technology, Department of Material Science and Chemical Engineering, Harbin Engineering University, Harbin, 15001, China
| | - Juncen Zhou
- Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794, USA
| | - Guo Jin
- Institute of Corrosion Science and Surface Technology, Department of Material Science and Chemical Engineering, Harbin Engineering University, Harbin, 15001, China
| | - Aldo R Boccaccini
- Institute of Biomaterials, University of Erlangen-Nuremberg, 91058 Erlangen, Germany
| | - Sannakaisa Virtanen
- Institute of Surface Science and Corrosion, University of Erlangen-Nuremberg, 91058 Erlangen, Germany
| |
Collapse
|
5
|
Chaudhary KR, Kujur S, Singh K. Recent advances of nanotechnology in COVID 19: A critical review and future perspective. OPENNANO 2023; 9. [PMCID: PMC9749399 DOI: 10.1016/j.onano.2022.100118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
The global anxiety and economic crisis causes the deadly pandemic coronavirus disease of 2019 (COVID 19) affect millions of people right now. Subsequently, this life threatened viral disease is caused due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, morbidity and mortality of infected patients are due to cytokines storm syndrome associated with lung injury and multiorgan failure caused by COVID 19. Thereafter, several methodological advances have been approved by WHO and US-FDA for the detection, diagnosis and control of this wide spreadable communicable disease but still facing multi-challenges to control. Herein, we majorly emphasize the current trends and future perspectives of nano-medicinal based approaches for the delivery of anti-COVID 19 therapeutic moieties. Interestingly, Nanoparticles (NPs) loaded with drug molecules or vaccines resemble morphological features of SARS-CoV-2 in their size (60–140 nm) and shape (circular or spherical) that particularly mimics the virus facilitating strong interaction between them. Indeed, the delivery of anti-COVID 19 cargos via a nanoparticle such as Lipidic nanoparticles, Polymeric nanoparticles, Metallic nanoparticles, and Multi-functionalized nanoparticles to overcome the drawbacks of conventional approaches, specifying the site-specific targeting with reduced drug loading and toxicities, exhibit their immense potential. Additionally, nano-technological based drug delivery with their peculiar characteristics of having low immunogenicity, tunable drug release, multidrug delivery, higher selectivity and specificity, higher efficacy and tolerability switch on the novel pathway for the prevention and treatment of COVID 19.
Collapse
Affiliation(s)
- Kabi Raj Chaudhary
- Department of Pharmaceutics, ISF College of Pharmacy, Ghal Kalan, Ferozpur G.T Road, Moga, Punjab 142001, India,Department of Research and Development, United Biotech (P) Ltd. Bagbania, Nalagarh, Solan, Himachal Pradesh, India,Corresponding author at: Department of Pharmaceutics, ISF College of Pharmacy, Ghal Kalan, Ferozpur G.T Road, MOGA, Punjab 142001, India
| | - Sima Kujur
- Department of Pharmaceutics, ISF College of Pharmacy, Ghal Kalan, Ferozpur G.T Road, Moga, Punjab 142001, India
| | - Karanvir Singh
- Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Ghal Kalan, Ferozpur G.T Road, Moga, Punjab 142001, India,Department of Research and Development, United Biotech (P) Ltd. Bagbania, Nalagarh, Solan, Himachal Pradesh, India
| |
Collapse
|
6
|
Fathy MM, Saad OA, Elshemey WM, Fahmy HM. Dose-enhancement of MCF 7 cell line radiotherapy using silica-iron oxide nanocomposite. Biochem Biophys Res Commun 2022; 632:100-106. [PMID: 36206593 DOI: 10.1016/j.bbrc.2022.09.087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2022] [Revised: 09/10/2022] [Accepted: 09/22/2022] [Indexed: 11/25/2022]
Abstract
Cancer radiotherapy is one of the most effective regimens of cancer treatments, but cancer cell radioresistance remains a concern. Radiosensitizers can selectively improve the efficacy of radiotherapy and reduce inherent damage. The purpose of this work is to evaluate the effect of silica-coated iron oxide magnetic nanoparticles (SIONPs) as a radiosensitizer and compare their therapeutic effect with that of Iron oxide magnetic nanoparticles (IONPs). IONPs and SIONPs were characterized using several physical techniques such as a transmission electron microscope (TEM) and Vibrating sample magnetometer (VSM). MTT and DNA double-strand breaks (Comet) assays have been used to detect the cytotoxicity, cell viability, and DNA damage of MCF-7 cells, which were treated with different concentrations of prepared nanoparticles and exposed to an X-ray beam. In this study, an efficient radiosensitizer, SIONPs, was successfully prepared and characterized. With 0.5 Gy dose, dose enhancement factor (DEF) values of cells treated with 5 and 10 μg/ml of IONPs were 1 and 1.09, respectively, while those treated with SIONPs at these concentrations had DEF of 1.21 and 1.32, respectively. Results demonstrated that SIONPs provide a potential for improving the radiosensitivity of breast cancer.
Collapse
|
7
|
Szymczyk A, Drozd M, Kamińska A, Matczuk M, Trzaskowski M, Mazurkiewicz-Pawlicka M, Ziółkowski R, Malinowska E. Comparative Evaluation of Different Surface Coatings of Fe3O4-Based Magnetic Nano Sorbent for Applications in the Nucleic Acids Extraction. Int J Mol Sci 2022; 23:ijms23168860. [PMID: 36012139 PMCID: PMC9408759 DOI: 10.3390/ijms23168860] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2022] [Revised: 08/01/2022] [Accepted: 08/07/2022] [Indexed: 11/16/2022] Open
Abstract
Nucleic acid extraction and purification are crucial steps in sample preparation for multiple diagnostic procedures. Routine methodologies of DNA isolation require benchtop equipment (e.g., centrifuges) and labor-intensive steps. Magnetic nanoparticles (MNPs) as solid-phase sorbents could simplify this procedure. A wide range of surface coatings employs various molecular interactions between dsDNA and magnetic nano-sorbents. However, a reliable, comparative evaluation of their performance is complex. In this work, selected Fe3O4 modifications, i.e., polyethyleneimine, gold, silica, and graphene derivatives, were comprehensively evaluated for applications in dsDNA extraction. A family of single batch nanoparticles was compared in terms of morphology (STEM), composition (ICP-MS/MS and elemental analysis), surface coating (UV-Vis, TGA, FTIR), and MNP charge (ζ-potential). ICP-MS/MS was also used to unify MNPs concentration allowing a reliable assessment of individual coatings on DNA extraction. Moreover, studies on adsorption medium (monovalent vs. divalent ions) and extraction buffer composition were carried out. As a result, essential relationships between nanoparticle coatings and DNA adsorption efficiencies have been noticed. Fe3O4@PEI MNPs turned out to be the most efficient nano sorbents. The optimized composition of the extraction buffer (medium containing 0.1 mM EDTA) helped avoid problems with Fe3+ stripping, which improved the validity of the spectroscopic determination of DNA recovery.
Collapse
Affiliation(s)
- Anna Szymczyk
- Chair of Medical Biotechnology, Faculty of Chemistry, Warsaw University of Technology, Stanisława Noakowskiego 3, 00-664 Warsaw, Poland
- Doctoral School No. 1, Warsaw University of Technology, Plac Politechniki 1, 00-661 Warsaw, Poland
| | - Marcin Drozd
- Chair of Medical Biotechnology, Faculty of Chemistry, Warsaw University of Technology, Stanisława Noakowskiego 3, 00-664 Warsaw, Poland
- Centre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, Poleczki 19, 02-822 Warsaw, Poland
| | - Agnieszka Kamińska
- Chair of Analytical Chemistry, Faculty of Chemistry, Warsaw University of Technology, Stanisława Noakowskiego 3, 00-664 Warsaw, Poland
| | - Magdalena Matczuk
- Chair of Analytical Chemistry, Faculty of Chemistry, Warsaw University of Technology, Stanisława Noakowskiego 3, 00-664 Warsaw, Poland
| | - Maciej Trzaskowski
- Centre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, Poleczki 19, 02-822 Warsaw, Poland
| | - Marta Mazurkiewicz-Pawlicka
- Faculty of Chemical and Process Engineering, Warsaw University of Technology, Ludwika Waryńskiego 1, 00-645 Warsaw, Poland
| | - Robert Ziółkowski
- Chair of Medical Biotechnology, Faculty of Chemistry, Warsaw University of Technology, Stanisława Noakowskiego 3, 00-664 Warsaw, Poland
- Correspondence:
| | - Elżbieta Malinowska
- Chair of Medical Biotechnology, Faculty of Chemistry, Warsaw University of Technology, Stanisława Noakowskiego 3, 00-664 Warsaw, Poland
- Centre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, Poleczki 19, 02-822 Warsaw, Poland
| |
Collapse
|
8
|
Khizar S, Al-Dossary AA, Zine N, Jaffrezic-Renault N, Errachid A, Elaissari A. Contribution of magnetic particles in molecular diagnosis of human viruses. Talanta 2022; 241:123243. [PMID: 35121538 PMCID: PMC8779935 DOI: 10.1016/j.talanta.2022.123243] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 01/17/2022] [Accepted: 01/18/2022] [Indexed: 12/16/2022]
Abstract
Viral diseases are the primary source of death, making a worldwide influence on healthcare, social, and economic development. Thus, diagnosis is the vital approach to the main aim of virus control and elimination. On the other hand, the prompt advancement of nanotechnology in the field of medicine possesses the probability of being beneficial to diagnose infections normally in labs as well as specifically. Nanoparticles are efficiently in use to make novel strategies because of permitting analysis at cellular in addition to the molecular scale. Henceforth, they assist towards pronounced progress concerning molecular analysis at the nanoscale. In recent times, magnetic nanoparticles conjugated through covalent bonds to bioanalytes for instance peptides, antibodies, nucleic acids, plus proteins are established like nanoprobes aimed at molecular recognition. These modified magnetic nanoparticles could offer a simple fast approach for extraction, purification, enrichment/concentration, besides viruses' recognition precisely also specifically. In consideration of the above, herein insight and outlook into the limitations of conventional methods and numerous roles played by magnetic nanoparticles to extract, purify, concentrate, and additionally in developing a diagnostic regime for viral outbreaks to combat viruses especially the ongoing novel coronavirus (COVID-19).
Collapse
Affiliation(s)
- Sumera Khizar
- Univ Lyon, Université Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, F-69622, Lyon, France
| | - Amal A. Al-Dossary
- Department of Basic Sciences, Deanship of Preparatory Year and Supporting Studies, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam, 34212, Saudi Arabia
| | - Nadia Zine
- Univ Lyon, Université Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, F-69622, Lyon, France
| | | | - Abdelhamid Errachid
- Univ Lyon, Université Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, F-69622, Lyon, France
| | - Abdelhamid Elaissari
- Univ Lyon, Université Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, F-69622, Lyon, France,Corresponding author. ISA, Université Claude Bernard Lyon-1, 5 rue de La Doua, Villeurbanne, 69100, France
| |
Collapse
|
9
|
Aghamirza Moghim Aliabadi H, Eivazzadeh‐Keihan R, Beig Parikhani A, Fattahi Mehraban S, Maleki A, Fereshteh S, Bazaz M, Zolriasatein A, Bozorgnia B, Rahmati S, Saberi F, Yousefi Najafabadi Z, Damough S, Mohseni S, Salehzadeh H, Khakyzadeh V, Madanchi H, Kardar GA, Zarrintaj P, Saeb MR, Mozafari M. COVID-19: A systematic review and update on prevention, diagnosis, and treatment. MedComm (Beijing) 2022; 3:e115. [PMID: 35281790 PMCID: PMC8906461 DOI: 10.1002/mco2.115] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2021] [Revised: 12/18/2021] [Accepted: 12/19/2021] [Indexed: 01/09/2023] Open
Abstract
Since the rapid onset of the COVID-19 or SARS-CoV-2 pandemic in the world in 2019, extensive studies have been conducted to unveil the behavior and emission pattern of the virus in order to determine the best ways to diagnosis of virus and thereof formulate effective drugs or vaccines to combat the disease. The emergence of novel diagnostic and therapeutic techniques considering the multiplicity of reports from one side and contradictions in assessments from the other side necessitates instantaneous updates on the progress of clinical investigations. There is also growing public anxiety from time to time mutation of COVID-19, as reflected in considerable mortality and transmission, respectively, from delta and Omicron variants. We comprehensively review and summarize different aspects of prevention, diagnosis, and treatment of COVID-19. First, biological characteristics of COVID-19 were explained from diagnosis standpoint. Thereafter, the preclinical animal models of COVID-19 were discussed to frame the symptoms and clinical effects of COVID-19 from patient to patient with treatment strategies and in-silico/computational biology. Finally, the opportunities and challenges of nanoscience/nanotechnology in identification, diagnosis, and treatment of COVID-19 were discussed. This review covers almost all SARS-CoV-2-related topics extensively to deepen the understanding of the latest achievements (last updated on January 11, 2022).
Collapse
Affiliation(s)
- Hooman Aghamirza Moghim Aliabadi
- Protein Chemistry LaboratoryDepartment of Medical BiotechnologyBiotechnology Research CenterPasteur Institute of IranTehranIran
- Advance Chemical Studies LaboratoryFaculty of ChemistryK. N. Toosi UniversityTehranIran
| | | | - Arezoo Beig Parikhani
- Department of Medical BiotechnologyBiotechnology Research CenterPasteur InstituteTehranIran
| | | | - Ali Maleki
- Department of ChemistryIran University of Science and TechnologyTehranIran
| | | | - Masoume Bazaz
- Department of Medical BiotechnologyBiotechnology Research CenterPasteur InstituteTehranIran
| | | | | | - Saman Rahmati
- Department of Medical BiotechnologyBiotechnology Research CenterPasteur InstituteTehranIran
| | - Fatemeh Saberi
- Department of Medical BiotechnologySchool of Advanced Technologies in MedicineShahid Beheshti University of Medical SciencesTehranIran
| | - Zeinab Yousefi Najafabadi
- Department of Medical BiotechnologySchool of Advanced Technologies in MedicineTehran University of Medical SciencesTehranIran
- ImmunologyAsthma & Allergy Research InstituteTehran University of Medical SciencesTehranIran
| | - Shadi Damough
- Department of Medical BiotechnologyBiotechnology Research CenterPasteur InstituteTehranIran
| | - Sara Mohseni
- Non‐metallic Materials Research GroupNiroo Research InstituteTehranIran
| | | | - Vahid Khakyzadeh
- Department of ChemistryK. N. Toosi University of TechnologyTehranIran
| | - Hamid Madanchi
- School of MedicineSemnan University of Medical SciencesSemnanIran
- Drug Design and Bioinformatics UnitDepartment of Medical BiotechnologyBiotechnology Research CenterPasteur Institute of IranTehranIran
| | - Gholam Ali Kardar
- Department of Medical BiotechnologySchool of Advanced Technologies in MedicineTehran University of Medical SciencesTehranIran
- ImmunologyAsthma & Allergy Research InstituteTehran University of Medical SciencesTehranIran
| | - Payam Zarrintaj
- School of Chemical EngineeringOklahoma State UniversityStillwaterOklahomaUSA
| | - Mohammad Reza Saeb
- Department of Polymer TechnologyFaculty of ChemistryGdańsk University of TechnologyGdańskPoland
| | - Masoud Mozafari
- Department of Tissue Engineering & Regenerative MedicineIran University of Medical SciencesTehranIran
| |
Collapse
|
10
|
Ramakrishnan SG, Robert B, Salim A, Ananthan P, Sivaramakrishnan M, Subramaniam S, Natesan S, Suresh R, Rajeshkumar G, Maran JP, Al-Dhabi NA, Karuppiah P, Valan Arasu M. Nanotechnology based solutions to combat zoonotic viruses with special attention to SARS, MERS, and COVID 19: Detection, protection and medication. Microb Pathog 2021; 159:105133. [PMID: 34390768 PMCID: PMC8358084 DOI: 10.1016/j.micpath.2021.105133] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2020] [Revised: 04/01/2021] [Accepted: 08/09/2021] [Indexed: 12/23/2022]
Abstract
Zoonotic viruses originate from birds or animal sources and responsible for disease transmission from animals to people through zoonotic spill over and presents a significant global health concern due to lack of rapid diagnostics and therapeutics. The Corona viruses (CoV) were known to be transmitted in mammals. Early this year, SARS-CoV-2, a novel strain of corona virus, was identified as the causative pathogen of an outbreak of viral pneumonia in Wuhan, China. The disease later named corona virus disease 2019 (COVID-19), subsequently spread across the globe rapidly. Nano-particles and viruses are comparable in size, which serves to be a major advantage of using nano-material in clinical strategy to combat viruses. Nanotechnology provides novel solutions against zoonotic viruses by providing cheap and efficient detection methods, novel, and new effective rapid diagnostics and therapeutics. The prospective of nanotechnology in COVID 19 is exceptionally high due to their small size, large surface-to-volume ratio, susceptibility to modification, intrinsic viricidal activity. The nano-based strategies address the COVID 19 by extending their role in i) designing nano-materials for drug/vaccine delivery, ii) developing nano-based diagnostic approaches like nano-sensors iii) novel nano-based personal protection equipment to be used in prevention strategies.This review aims to bring attention to the significant contribution of nanotechnology to mitigate against zoonotic viral pandemics by prevention, faster diagnosis and medication point of view.
Collapse
Affiliation(s)
- Sankar Ganesh Ramakrishnan
- Bioprocess and Biomaterials laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, India
| | - Becky Robert
- Bioprocess and Biomaterials laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, India
| | - Anisha Salim
- Bioprocess and Biomaterials laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, India
| | - Padma Ananthan
- School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom
| | | | - Sadhasivam Subramaniam
- Bioprocess and Biomaterials laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, India; Department of Extension and Career Guidance, Bharathiar University, Coimbatore, India.
| | - Sivarajasekar Natesan
- Unit Operations laboratory, Department of Biotechnology, Kumaraguru College of Technology, Coimbatore, India
| | - Rahul Suresh
- Department of Physics, Bharathiar University, Coimbatore, India
| | - G Rajeshkumar
- Department of Mechanical Engineering, PSG Institute of Technology and Applied Research, Coimbatore, Tamilnadu, India
| | - J Prakash Maran
- Department of Food Science and Nutrition, Periyar University, Salem, Tamilnadu, India.
| | - Naif Abdullah Al-Dhabi
- Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia
| | - Ponmurugan Karuppiah
- Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.
| | - Mariadhas Valan Arasu
- Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia
| |
Collapse
|
11
|
Derakhshan MA, Amani A, Faridi-Majidi R. State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2. ACS APPLIED MATERIALS & INTERFACES 2021; 13:14816-14843. [PMID: 33779135 PMCID: PMC8028022 DOI: 10.1021/acsami.0c22381] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/30/2020] [Accepted: 03/17/2021] [Indexed: 05/02/2023]
Abstract
The pandemic outbreak of SARS-CoV-2, with millions of infected patients worldwide, has severely challenged all aspects of public health. In this regard, early and rapid detection of infected cases and providing effective therapeutics against the virus are in urgent demand. Along with conventional clinical protocols, nanomaterial-based diagnostics and therapeutics hold a great potential against coronavirus disease 2019 (COVID-19). Indeed, nanoparticles with their outstanding characteristics would render additional advantages to the current approaches for rapid and accurate diagnosis and also developing prophylactic vaccines or antiviral therapeutics. In this review, besides presenting an overview of the coronaviruses and SARS-CoV-2, we discuss the introduced nanomaterial-based detection assays and devices and also antiviral formulations and vaccines for coronaviruses.
Collapse
Affiliation(s)
- Mohammad Ali Derakhshan
- Department
of Medical Nanotechnology, School of Advanced Medical Sciences and
Technologies, Shiraz University of Medical
Sciences, Shiraz, Iran
- Nanomedicine
and Nanobiology Research Center, Shiraz
University of Medical Sciences, Shiraz Iran
| | - Amir Amani
- Natural
Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran
| | - Reza Faridi-Majidi
- Department
of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
12
|
Tabasi H, Hamed Mosavian M, Sabouri Z, Khazaei M, Darroudi M. pH-responsive and CD44-targeting by Fe3O4/MSNs-NH2 nanocarriers for Oxaliplatin loading and colon cancer treatment. INORG CHEM COMMUN 2021. [DOI: 10.1016/j.inoche.2020.108430] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
|
13
|
Kobyliukh A, Olszowska K, Szeluga U, Pusz S. Iron oxides/graphene hybrid structures - Preparation, modification, and application as fillers of polymer composites. Adv Colloid Interface Sci 2020; 285:102285. [PMID: 33070104 DOI: 10.1016/j.cis.2020.102285] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2020] [Revised: 09/30/2020] [Accepted: 10/10/2020] [Indexed: 01/06/2023]
Abstract
The current status of knowledge regarding magnetic hybrid structures based on graphene or carbon nanotubes with various forms of iron oxides is reviewed. The paper starts with a summary of the preparation and properties of iron oxide nanoparticles, both untreated and coated with silica or polymer layers. In the next section, organic-inorganic hybrid materials obtained as a result of a combination of graphene or carbon nanotubes and iron chemical compounds are characterized and discussed. These hybrids constitute an increasing percentage of all consumable high performance biomedical, electronic, and energy materials due to their valuable properties and low production costs. The potential of their application as components of materials used in corrosion protection, catalysis, spintronics, biomedicine, photoelectrochemical water splitting and groundwater remediation, as well as magnetic nanoparticles in polymer matrices, are also presented. The last part of this review article is focused on reporting the most recent developments in design and the understanding of the properties of polymer composites reinforced with nanometer-sized iron oxide/graphene and iron oxide/carbon nanotubes hybrid fillers. The discussion presents comparative analysis of the magnetic, electromagnetic shielding, electrical, thermal, and mechanical properties of polymer composites with various iron oxide/graphene structures. It is shown that the introduction of hybrid filler nanoparticles into polymer matrices enhances both the macro- and microproperties of final composites as a result of synergistic effects of individual components and the simultaneous formation of an oriented filler network in the polymer. The reinforcing effect is related to the structure and geometry of hybrid nanoparticles applied as a filler, the interactions between the filler particles, their concentration in a composite, and the method of composite processing.
Collapse
Affiliation(s)
- Anastasiia Kobyliukh
- Centre of Polymer and Carbon Materials, Polish Academy of Sciences, M. Curie-Skłodowskiej 34, Zabrze, Poland
| | - Karolina Olszowska
- Centre of Polymer and Carbon Materials, Polish Academy of Sciences, M. Curie-Skłodowskiej 34, Zabrze, Poland
| | - Urszula Szeluga
- Centre of Polymer and Carbon Materials, Polish Academy of Sciences, M. Curie-Skłodowskiej 34, Zabrze, Poland.
| | - Sławomira Pusz
- Centre of Polymer and Carbon Materials, Polish Academy of Sciences, M. Curie-Skłodowskiej 34, Zabrze, Poland
| |
Collapse
|
14
|
Medhi R, Srinoi P, Ngo N, Tran HV, Lee TR. Nanoparticle-Based Strategies to Combat COVID-19. ACS APPLIED NANO MATERIALS 2020; 3:8557-8580. [PMID: 37556239 PMCID: PMC7482545 DOI: 10.1021/acsanm.0c01978] [Citation(s) in RCA: 102] [Impact Index Per Article: 25.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Accepted: 08/26/2020] [Indexed: 05/05/2023]
Abstract
Coronavirus disease 2019 (COVID-19) is the worst pandemic disease of the current millennium. This disease is caused by the highly contagious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first exhibited human-to-human transmission in December 2019 and has infected millions of people within months across 213 different countries. Its ability to be transmitted by asymptomatic carriers has put a massive strain on the currently available testing resources. Currently, there are no clinically proven therapeutic methods that clearly inhibit the effects of this virus, and COVID-19 vaccines are still in the development phase. Strategies need to be explored to expand testing capacities, to develop effective therapeutics, and to develop safe vaccines that provide lasting immunity. Nanoparticles (NPs) have been widely used in many medical applications, such as biosensing, drug delivery, imaging, and antimicrobial treatment. SARS-CoV-2 is an enveloped virus with particle-like characteristics and a diameter of 60-140 nm. Synthetic NPs can closely mimic the virus and interact strongly with its proteins due to their morphological similarities. Hence, NP-based strategies for tackling this virus have immense potential. NPs have been previously found to be effective tools against many viruses, especially against those from the Coronaviridae family. This Review outlines the role of NPs in diagnostics, therapeutics, and vaccination for the other two epidemic coronaviruses, the 2003 severe acute respiratory syndrome (SARS) virus and the 2012 Middle East respiratory syndrome (MERS) virus. We also highlight nanomaterial-based approaches to address other coronaviruses, such as human coronaviruses (HCoVs); feline coronavirus (FCoV); avian coronavirus infectious bronchitis virus (IBV); coronavirus models, such as porcine epidemic diarrhea virus (PEDV), porcine reproductive and respiratory syndrome virus (PRRSV), and transmissible gastroenteritis virus (TGEV); and other viruses that share similarities with SARS-CoV-2. This Review combines the salient principles from previous antiviral studies with recent research conducted on SARS-CoV-2 to outline NP-based strategies that can be used to combat COVID-19 and similar pandemics in the future.
Collapse
Affiliation(s)
- Riddhiman Medhi
- Department of Chemistry and the Texas Center for
Superconductivity, University of Houston, 4800 Calhoun Road,
Houston, Texas 77204-5003, United States
| | - Pannaree Srinoi
- Department of Chemistry and the Texas Center for
Superconductivity, University of Houston, 4800 Calhoun Road,
Houston, Texas 77204-5003, United States
| | - Nhat Ngo
- Department of Chemistry and the Texas Center for
Superconductivity, University of Houston, 4800 Calhoun Road,
Houston, Texas 77204-5003, United States
| | - Hung-Vu Tran
- Department of Chemistry and the Texas Center for
Superconductivity, University of Houston, 4800 Calhoun Road,
Houston, Texas 77204-5003, United States
| | - T. Randall Lee
- Department of Chemistry and the Texas Center for
Superconductivity, University of Houston, 4800 Calhoun Road,
Houston, Texas 77204-5003, United States
| |
Collapse
|
15
|
Klein S, Müller TG, Khalid D, Sonntag-Buck V, Heuser AM, Glass B, Meurer M, Morales I, Schillak A, Freistaedter A, Ambiel I, Winter SL, Zimmermann L, Naumoska T, Bubeck F, Kirrmaier D, Ullrich S, Barreto Miranda I, Anders S, Grimm D, Schnitzler P, Knop M, Kräusslich HG, Dao Thi VL, Börner K, Chlanda P. SARS-CoV-2 RNA Extraction Using Magnetic Beads for Rapid Large-Scale Testing by RT-qPCR and RT-LAMP. Viruses 2020; 12:E863. [PMID: 32784757 PMCID: PMC7472728 DOI: 10.3390/v12080863] [Citation(s) in RCA: 70] [Impact Index Per Article: 17.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2020] [Revised: 07/31/2020] [Accepted: 08/05/2020] [Indexed: 01/01/2023] Open
Abstract
Rapid large-scale testing is essential for controlling the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The standard diagnostic pipeline for testing SARS-CoV-2 presence in patients with an ongoing infection is predominantly based on pharyngeal swabs, from which the viral RNA is extracted using commercial kits, followed by reverse transcription and quantitative PCR detection. As a result of the large demand for testing, commercial RNA extraction kits may be limited and, alternatively, non-commercial protocols are needed. Here, we provide a magnetic bead RNA extraction protocol that is predominantly based on in-house made reagents and is performed in 96-well plates supporting large-scale testing. Magnetic bead RNA extraction was benchmarked against the commercial QIAcube extraction platform. Comparable viral RNA detection sensitivity and specificity were obtained by fluorescent and colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) using a primer set targeting the N gene, as well as RT-qPCR using a primer set targeting the E gene, showing that the RNA extraction protocol presented here can be combined with a variety of detection methods at high throughput. Importantly, the presented diagnostic workflow can be quickly set up in a laboratory without access to an automated pipetting robot.
Collapse
Affiliation(s)
- Steffen Klein
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
- Schaller Research Groups, Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany
| | - Thorsten G. Müller
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
| | - Dina Khalid
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
| | - Vera Sonntag-Buck
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
| | - Anke-Mareil Heuser
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
| | - Bärbel Glass
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
| | - Matthias Meurer
- Center for Molecular Biology of Heidelberg University (ZMBH), 69120 Heidelberg, Germany; (M.M.); (D.K.); (S.A.); (M.K.)
- German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
| | - Ivonne Morales
- Center of Infectious Diseases, Clinical Tropical Medicine, Heidelberg University Hospital, 69120 Heidelberg, Germany;
| | - Angelika Schillak
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
| | - Andrew Freistaedter
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
| | - Ina Ambiel
- Center of Infectious Diseases, Integrative Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany;
| | - Sophie L. Winter
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
- Schaller Research Groups, Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany
| | - Liv Zimmermann
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
| | - Tamara Naumoska
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
| | - Felix Bubeck
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
| | - Daniel Kirrmaier
- Center for Molecular Biology of Heidelberg University (ZMBH), 69120 Heidelberg, Germany; (M.M.); (D.K.); (S.A.); (M.K.)
- German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
| | - Stephanie Ullrich
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
| | - Isabel Barreto Miranda
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
| | - Simon Anders
- Center for Molecular Biology of Heidelberg University (ZMBH), 69120 Heidelberg, Germany; (M.M.); (D.K.); (S.A.); (M.K.)
| | - Dirk Grimm
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
- German Center for Infection Research (DZIF), 69120 Heidelberg, Germany
| | - Paul Schnitzler
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
| | - Michael Knop
- Center for Molecular Biology of Heidelberg University (ZMBH), 69120 Heidelberg, Germany; (M.M.); (D.K.); (S.A.); (M.K.)
- German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
- DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany
| | - Hans-Georg Kräusslich
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
- German Center for Infection Research (DZIF), 69120 Heidelberg, Germany
| | - Viet Loan Dao Thi
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
- Schaller Research Groups, Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany
| | - Kathleen Börner
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
- German Center for Infection Research (DZIF), 69120 Heidelberg, Germany
| | - Petr Chlanda
- Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; (S.K.); (T.G.M.); (D.K.); (V.S.-B.); (A.-M.H.); (B.G.); (A.S.); (A.F.); (S.L.W.); (L.Z.); (T.N.); (F.B.); (S.U.); (I.B.M.); (D.G.); (P.S.); (H.-G.K.); (V.L.D.T.)
- Schaller Research Groups, Center of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany
| |
Collapse
|
16
|
B. Somvanshi S, B. Kharat P, S. Saraf T, B. Somwanshi S, B. Shejul S, M. Jadhav K. Multifunctional nano-magnetic particles assisted viral RNA-extraction protocol for potential detection of COVID-19. ACTA ACUST UNITED AC 2020. [PMCID: PMC7256346 DOI: 10.1080/14328917.2020.1769350] [Citation(s) in RCA: 59] [Impact Index Per Article: 14.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
The enduring outbreak of the corona virus disease (COVID-19) originated from China illustrates global concerns owing to their infective nature and time-consuming incubation. Even though diagnostic tools based on RT-PCR are being extensively employed at present, well-timed and precise diagnostics are still restricted because of the long-period and exhaustive man-power requirement. To tackle this problem, we herewith report the fabrication of the surface functionalised magnetic nanoparticles (MNP’s) and viral RNA-extraction protocol for potential detection of COVID-19. The zinc ferrite nanoparticles were prepared by combustion synthesis and its surface was functionalised by silica and carboxyl-modified polyvinyl alcohol. The MNP’s were characterized to confirm the nano-scale appearance and functionalization. The proposed model may provide the ability to extract the viral RNA from several specimens through automation process. In light of ease and proficiency, this protocol may significantly lessen the operation period and necessities for the present molecular-level diagnostic of COVID-19.
Collapse
Affiliation(s)
- Sandeep B. Somvanshi
- Department of Physics, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, India
| | - Prashant B. Kharat
- Department of Physics, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, India
- Department of Physics, Vinayak Vidnyan Mahavidyalaya, Nandgaon Khandeshwar, Amravati, India
| | - Tukaram S. Saraf
- Department of Physics, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, India
| | - Saurabh B. Somwanshi
- Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, India
| | - Sumit B. Shejul
- Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, India
| | - Kamalakar M. Jadhav
- Department of Physics, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, India
| |
Collapse
|
17
|
Fathy MM, Fahmy HM, Saad OA, Elshemey WM. Silica-coated iron oxide nanoparticles as a novel nano-radiosensitizer for electron therapy. Life Sci 2019; 234:116756. [DOI: 10.1016/j.lfs.2019.116756] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2019] [Revised: 08/09/2019] [Accepted: 08/12/2019] [Indexed: 12/31/2022]
|
18
|
Popkov V, Tolstoy V, Nevedomskiy V. Peroxide route to the synthesis of ultrafine CeO 2-Fe 2O 3 nanocomposite via successive ionic layer deposition. Heliyon 2019; 5:e01443. [PMID: 30976704 PMCID: PMC6441835 DOI: 10.1016/j.heliyon.2019.e01443] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2019] [Revised: 03/04/2019] [Accepted: 03/25/2019] [Indexed: 02/06/2023] Open
Abstract
An ultrafine α-CeO2-α-Fe2O3 nanocomposite was prepared from the ultradispersed nanoparticles of cerium (IV) and iron (III) amorphous hydroxides heat-treated at 600 °С and 900 °С in the air. The initial composites were obtained by the successive ionic layer deposition (SILD) method. According to scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDX) and powder X-ray diffraction (PXRD), the cerium/iron ratio in the synthesized nanocomposite is close to 1:2, and the α-CeO2 and α-Fe2O3 nanocrystals are isometrically shaped and have an average size of 4 ± 1 and 7 ± 1 nm (600 °С) and 24 ± 2 and 35 ± 3 nm (900 °С), respectively. Transmission electron microscopy (TEM) and selected area electron diffraction (SAED) have shown that nanocrystals are evenly distributed in the composite volume and are spatially conjugated. The formation mechanisms of both initial amorphous composites of cerium (IV) and iron (III) hydroxides and of α-CeO2 and α-Fe2O3 nanocrystals were established. It was shown that synthesis of the initial hydroxide composite using the SILD method proceeds via the formation of amorphous cerium hydroxo-peroxide (CeO(OOH)2). As a result of the study, a schematic mechanism for the formation of a composite based on ultrafine nanocrystals of cerium (IV) and iron (III) oxides has been proposed.
Collapse
Affiliation(s)
- V.I. Popkov
- Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Prospect, Petergof, St. Petersburg, 198504, Russian Federation
- Ioffe Institute, 26 Politekhnicheskaya Street, St. Petersburg, 194021, Russian Federation
- Saint-Petersburg State Institute of Technology, 26 Moskovsky Prospect, St. Petersburg, 190013, Russian Federation
| | - V.P. Tolstoy
- Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Prospect, Petergof, St. Petersburg, 198504, Russian Federation
| | - V.N. Nevedomskiy
- Ioffe Institute, 26 Politekhnicheskaya Street, St. Petersburg, 194021, Russian Federation
| |
Collapse
|